Finance

Lists
Why is NAMS down ५.६४%?
Dive Deeper
NAMS:NASDAQ
NewAmsterdam Pharma Company NV
US$ १८.४१
-५.६४%
(-१.१०) 1D
US$ १८.३२
-०.४९% (-०.०९०)
After hours
Closed: नोभेम्बर २०, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAMS...
Open
US$ १९.२१
High
US$ १९.७८
Low
US$ १८.२८
Mkt. cap
२.२१ अरब
Avg. vol.
१६.६९ लाख
Volume
१७.४५ लाख
52-wk high
US$ ४२.२०
52-wk low
US$ १७.९०
EPS
-US$ १.६८
Beta
०.१४
Shares outstanding
११.९९ करोड
No. of employees
१००
Open
US$ १९.२१
High
US$ १९.७८
Low
US$ १८.२८
Mkt. cap
२.२१ अरब
Avg. vol.
१६.६९ लाख
Volume
१७.४५ लाख
52-wk high
US$ ४२.२०
52-wk low
US$ १७.९०
EPS
-US$ १.६८
Beta
०.१४
Shares outstanding
११.९९ करोड
No. of employees
१००
News stories
From web sources and news partners
Bloomberg.com
Bloomberg.com
·
४५ मिनेट पहिले
Yardeni Cuts S&P 500 Target Again, Says Bear Market Is Unlikely
BigGo Finance
BigGo Finance
·
२ घण्टा पहिले
S&P 500 Slides Into Correction as Wall Street Hunts for a Bottom Signal
About NewAmsterdam Pharma Company NV
CEO-
Employees१००
Founded२०१९
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 11 analysts giving stock ratings to NAMS in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for NAMS in the last 3 months.
Highest
Current US$ १८.४१
US$ ६१.०० (+२३१.३४%)
Average
US$ ५४.७० (+१९७.१२%)
Lowest
US$ ४२.०० (+१२८.१४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$ ६१.००
+२३१.३%
11/10/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
US$ ५०.००
+१७१.६%
11/09/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ ६०.००
+२२५.९%
11/09/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$ ५२.००
+१८२.५%
11/06/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$ ५७.००
+२०९.६%
11/05/2026
Conor MacKay
BMO Capital
Buy
Maintained
US$ ५८.००
+२१५%
11/05/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
US$ ४२.००
+१२८.१%
11/04/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
US$ ५५.००
+१९८.८%
11/05/2026
Geoff Meacham
Citi
Buy
Maintained
US$ ५५.००
+१९८.८%
10/15/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
US$ ५७.००
+२०९.६%
09/22/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/18/2026
Serge Belanger
Needham
Buy
Maintained
US$ ४८.००
+१६०.७%
08/07/2026
Unknown Analyst
Citi
Buy
Maintained
US$ ५५.००
+१९८.८%
08/06/2026
Evan Seigerman
BMO Capital
Buy
Initiated
US$ ५८.००
+२१५%
07/21/2026
Unknown Analyst
BMO Capital
Buy
Initiated
US$ ५८.००
+२१५%
07/20/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
US$ ४५.००
+१४४.४%
05/07/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/07/2026
Asad Haider
Goldman Sachs
Hold
Maintained
US$ ३८.००
+१०६.४%
05/07/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$ ४५.००
+१४४.४%
04/02/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
३२.०० हजार
३०.४० लाख
३७.०१ लाख
१.९२ करोड
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
३.८६ करोड
३.८० करोड
४.१७ करोड
३.९४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.७४ करोड
२.३५ करोड
२.६९ करोड
२.४० करोड
Operating expense
६.६० करोड
६.१५ करोड
६.८६ करोड
६.३४ करोड
Total operating expenses
६.६० करोड
६.१५ करोड
६.८६ करोड
६.३४ करोड
Operating income
-६.६० करोड
-५.८४ करोड
-६.४९ करोड
-४.४२ करोड
Other non operating income
-१.५३ करोड
५९.४२ लाख
-४५.५५ लाख
२.३१ करोड
EBT including unusual items
-७.४९ करोड
-४.८४ करोड
-६.४१ करोड
-१.६२ करोड
EBT excluding unusual items
-७.४९ करोड
-४.८४ करोड
-६.४१ करोड
-१.६२ करोड
Income tax expense
-
-
-
१२.०७ लाख
Effective tax rate
-
-
-
-७.४६%
Other operating expenses
-
-
-
-
Net income
-७.४९ करोड
-४.८४ करोड
-६.४१ करोड
-१.७४ करोड
Net profit margin
-२,३४,१३४.३८%
-१,५९३.४५%
-१,७३२.९१%
-९०.७४%
Earnings per share
-
-
-
-
Interest and investment income
६४.७३ लाख
५६.५० लाख
५८.१० लाख
५१.८७ लाख
Interest expense
-
-
-
-
Net interest expenses
६४.७३ लाख
५६.५० लाख
५८.१० लाख
५१.८७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-६.५९ करोड
-५.८४ करोड
-६.४८ करोड
-४.४१ करोड
Gain or loss from assets sale
११.०० हजार
१२.०० हजार
६.०० हजार
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू